![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessA comparative study on the validations of three cognitive screening tests in identifying subtle cognitive decline
Subtle cognitive decline (SCD) may represent a very early stage of objective cognitive impairment before mild cognitive impairment (MCI), with less neuronal damage and more functional reservation. Detecting in...
-
Article
Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer's disease
Huperzine A isolated from the Chinese herb Huperzia serrata (Thunb) Trev is a novel reversible and selective AChE inhibitor. The aim of this study was to evaluate the pharmacokinetics and tolerance of single a...
-
Article
Open AccessMemory and Executive Screening (MES): a brief cognitive test for detecting mild cognitive impairment
Mild cognitive impairment (MCI), defined as a transitional zone between normal cognition and dementia, requires a battery of formal neuropsychological tests administered by a trained rater for its diagnosis. T...
-
Article
Synthesis and magnetic properties of copper(II)-cobalt(II) complexes ofN,N′-1,2-propanedisalicylamidatocuprate(II)
The binuclear metal complexes [Cu(sampn)Co(L)2] (L=bipy, phen), have been prepared by the reaction of sodiumN,N′-1,2-propanedisalicylamidatocuprate(II) heptahydrate, Na2[Cu(sampn)] 7H2O, with a divalent metalion,...